RxDoctor Payments Data

Laura Keane

Psychiatric/Mental Health · Plattsburgh, NYNPI 1700458114

Payments from drug & device makers

$893in general payments, 2019–2025

Across 46 payments — averaging $19.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$181
  • AbbVie$176
  • E.r. Squibb & Sons, L.L.C.$93
  • Neurocrine Biosciences, Inc.$87
  • Otsuka America Pharmaceutical, Inc.$60
  • Lundbeck LLC$53
  • plus $243 from 7 others

What the payments were for

  • Food & beverage$893100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$893 in reported general payments places this provider in the 60th percentile of 2,385 psychiatric/mental health providers in New York.

See all psychiatric/mental health providers in New York

Medicare billing

Part B allowed, 2024
$33,894
Medicare patients
49
Services billed
441

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Abilify MaintenaAripiprazole44$128,764
IngrezzaValbenazine Tosylate12$95,908
VraylarCariprazine Hcl59$83,585
Lurasidone Hcl72$13,729
Ramelteon45$5,692
Vilazodone Hcl53$4,642
Aripiprazole91$4,046
Hydroxyzine Hcl165$3,340
Lisdexamfetamine Dimesylate12$2,897
Quetiapine Fumarate ErQuetiapine Fumarate24$2,837
Prazosin Hcl192$2,223
Quetiapine Fumarate172$2,195
Clozapine72$2,135
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine30$1,991
Divalproex Sodium ErDivalproex Sodium36$1,754

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena$60$128,76444 claims
Neurocrine Biosciences, Inc.Ingrezza$87$95,90812 claims
AbbVieVraylar$176$83,58559 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,385 psychiatric/mental health providers in New York.

Other psychiatric/mental health in Plattsburgh

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →